October 1 2010 | Press Release
Dubai, U.A.E (1 October 2010) Nucletron, a leading provider of state of the art radiotherapy solutions for cancer treatment, announced the opening of a new office in Dubai, expanding its presence in precision cancer treatment to emerging markets in the Middle East and Africa. Nucletron strongly believes in the benefits that its solutions will bring for patients in these areas and is looking forward to closely cooperating with leading clinics to broadening access to brachytherapy. Ahmed Taha has been appointed to the role of General Manager of the Dubai office. Taha, a surgeon by training, brings 14 years of experience in the health sector in the Middle East and Africa. During ESTRO in Barcelona earlier this year, Taha was introduced to a number of key customers in the area. Nucletron will be able to better serve the needs of its customers in the Middle East and Africa, with direct and fast support.
said Dr Mervat Elnagar, Head of Radiotherapy, NCI, Cairo, Egypt. “I am looking forward to working with them to help bring the cancer treatment solutions that they offer to my patients. With a new office in Dubai, I am sure that Nucletron can help us in treating and beating cancer.” “The opening of our office in Dubai is a key development in our efforts to better cooperate with clinicians in emerging markets, in order to make our solutions for precision cancer treatment available to all cancer patients,” says Arjen van ‘t Hooft, Vice President Emerging Markets at Nucletron. “We will now be able to better support our customers in achieving better treatment for cancer patients in these areas.” About Nucletron Nucletron provides state of the art radiotherapy solutions for cancer treatment that meet the evolving needs of patients, their caregivers and healthcare professionals around the world. Nucletron has unmatched global leadership in brachytherapy, a very precise, highly effective and well-tolerated treatment option for healthcare providers, tailored to the needs of individual patients. We work with clinical teams to constantly improve and develop an innovative portfolio of integrated products, software and services that assures excellent patient outcomes. Headquartered in Veenendaal, The Netherlands, Nucletron employs more than 500 employees, with offices in 16 countries, and products available in more than 100 countries around the world. Please visit http://www.nucletron.com/ to learn more about our healthcare solutions.